about   CII home   shop   checkout

Featured Events and News

Register by Oct 23 & Save €300
Visit Event Website
Register by Nov 6 & Save $300
Visit Event Website
Register by Nov 13 & Save $500
Visit Event Website

Recent Posts

09.09.20 Medtech Conference June 15-16, 2021 Minneapolis confirmed

10.16.20 SCOPE USA preliminary agenda announced

10.19.20 OPT Congress Virtual starts 10.20.20

09.18.20 Discovery on Target Virtual is now Available On-Demand

09.21.20 SCOPE Summit Europe & Clinical Trial Innovation Summit Virtual Final Agenda Now Available

Superpower Research: CHI’s Virtual Events

CHI is proud to be a leader in developing the pathways that spark research innovations, and in connecting the people who drive them, by presenting real-time research and technologies, novel discoveries and best practices from industry front runners.

At Your Convenience: On-Demand Access

Content for any of our Cambridge Healthtech Institute virtual events is also accessible on-demand for one year. Revisit any session from your virtual event to gain a more in-depth understanding of your research topic, or attend any session you may have missed, from anywhere, on any device.

Connect with the Life Science Community

Cambridge Healthtech Institute keeps the life science community connected and delivers the latest research, science, and solutions for exploring the future of precision medicine, diagnostics and innovative technologies… all without leaving your computer. Participate in these webinars today.

Looking for more of our most popular Events?
Click here to view our Key Conferences.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett International, Cambridge Meeting Planners and Healthtech Publishing, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.

NEW - The Chain: Protein
Engineering Podcast

The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up-to-date on the newest advancements and to hear the stories that are impacting the world of biologics.

Opportunities to Grow, Learn and Participate

Latest News from our Publications

Clinical Data Visualizations at BMS Merge Trial and Real-World Data
TODAY | Bio-IT World  The probability of success is low in early drug discovery and gets progressively more expensive on the journey to marketing approval by the Food and Drug Administration (FDA). To “fail early and fail often” has thus become the mantra of medicine developers needing to direct resources to the candidates most likely to triumph, says Philip Ross, director of translational bioinformatics data science at Bristol-Myers Squibb (BMS). Only 9.6% of drugs that make it to phase I trials ever get FDA approved. Read MoreView More Articles